Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.

× No keyword cloud information.

24 in total

1. The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics.

Authors: A Rifkin; F Quitkin; J Kane; D F Klein; D Ross
Journal: Biol Psychiatry Date: 1979-06 Impact factor: 13.382

2. Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community.

Authors: B C Stevens
Journal: Psychol Med Date: 1973-05 Impact factor: 7.723

3. Trial of maintenance therapy in schizophrenia.

Authors: J P Leff; J K Wing
Journal: Br Med J Date: 1971-09-11

4. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.

Authors: T Kolivakis; H Azim; E Kingstone
Journal: Curr Ther Res Clin Exp Date: 1974-09

5. Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride.

Authors: G E Hogarty; N R Schooler; R Ulrich; F Mussare; P Ferro; E Herron
Journal: Arch Gen Psychiatry Date: 1979-11

6. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.

Authors: I Falloon; D C Watt; M Shepherd
Journal: Psychol Med Date: 1978-02 Impact factor: 7.723

7. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Authors: S R Hirsch; R Gaind; P D Rohde; B C Stevens; J K Wing
Journal: Br Med J Date: 1973-03-17

8. Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate.

Authors: N R Schooler; J Levine; J B Severe; B Brauzer; A DiMascio; G L Klerman; V B Tuason
Journal: Arch Gen Psychiatry Date: 1980-01

9. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.

Authors: I Falloon; D C Watt; M Shepherd
Journal: Psychol Med Date: 1978-05 Impact factor: 7.723

10. Important issues in the drug treatment of schizophrenia.

Authors: J M Davis; C B Schaffer; G A Killian; C Kinard; C Chan
Journal: Schizophr Bull Date: 1980 Impact factor: 9.306

7 in total

1. Does short term placebo treatment of chronic schizophrenia produce long term harm?

Authors: D A Curson; S R Hirsch; S D Platt; R W Bamber; T R Barnes
Journal: Br Med J (Clin Res Ed) Date: 1986-09-20

2. Relationship between symptomatology and social disability. Empirical evidence from a follow-up study of schizophrenic patients.

Authors: A DeJong; R Giel; C J Slooff; D Wiersma
Journal: Soc Psychiatry Date: 1986

3. Psychiatric morbidity of a long stay hospital population with chronic schizophrenia and implications for future community care.

Authors: D A Curson; M Patel; P F Liddle; T R Barnes
Journal: BMJ Date: 1988-10-01

4. Multidimensional study of the outcome of schizophrenic patients 1 year after clinic discharge. Predictors and influence of neuroleptic treatment.

Authors: W Gaebel; A Pietzcker
Journal: Eur Arch Psychiatry Neurol Sci Date: 1985

5. Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.

Authors: Taishiro Kishimoto; Alfred Robenzadeh; Claudia Leucht; Stefan Leucht; Koichiro Watanabe; Masaru Mimura; Michael Borenstein; John M Kane; Christoph U Correll
Journal: Schizophr Bull Date: 2012-12-17 Impact factor: 9.306

Review 6. Long-term depot antipsychotics. A risk-benefit assessment.

Authors: T R Barnes; D A Curson
Journal: Drug Saf Date: 1994-06 Impact factor: 5.606

Review 7. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.

Authors: Jataveda Mahapatra; Seema N Quraishi; Anthony David; Stephanie Sampson; Clive E Adams
Journal: Cochrane Database Syst Rev Date: 2014-06-10

7 in total